SWX:PPGNLife Sciences
PolyPeptide Group (SWX:PPGN) Stock Could Be 8.9% Overvalued After Return To Profit
PolyPeptide Group (SWX:PPGN) has attracted fresh attention after swinging from a net loss to a net profit in its latest quarter, a shift that coincides with supportive analyst sentiment.
See our latest analysis for PolyPeptide Group.
The recent swing to profit appears to have coincided with a sharp improvement in sentiment, with PolyPeptide Group’s share price at CHF39.35 delivering a 59.96% 90 day share price return and a 98.14% 1 year total shareholder return, even though the 5 year total...